This is not the most recent version of the article. View current version (14 APR 2010)

Intervention Protocol

Cerebrolysin for acute ischemic stroke

  1. Lilia E Ziganshina1,*,
  2. Tatyana Abakumova2,
  3. Alexandra Kuchaeva2

Editorial Group: Cochrane Stroke Group

Published Online: 23 APR 2008

Assessed as up-to-date: 24 OCT 2007

DOI: 10.1002/14651858.CD007026


How to Cite

Ziganshina LE, Abakumova T, Kuchaeva A. Cerebrolysin for acute ischemic stroke (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD007026. DOI: 10.1002/14651858.CD007026.

Author Information

  1. 1

    Kazan State Medical Academy , Department of Clinical Pharmacology and Pharmacotherapy, Kazan, Tatarstan, Russia

  2. 2

    Kazan State Medical Academy, Department of Clinical Pharmacology and Pharmacotherapy, Kazan, Republic of Tatarstan, Russia

*Lilia E Ziganshina, Department of Clinical Pharmacology and Pharmacotherapy, Kazan State Medical Academy , 11 Mushtari Street, 420012, 14-15 Malaya Krasnaya Street, 420015, Kazan, Tatarstan, Russia. lezign@mail.ru. lezign@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 APR 2008

SEARCH

This is not the most recent version of the article. View current version (14 APR 2010)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

(1) To assess the benefits and risks of cerebrolysin for treating acute ischemic stroke.
(2) To estimate the effect of cerebrolysin on survival and disability .
(3) To assess serious adverse events and adverse effects.